Mark Bodenrader
Overview
Mark Bodenrader received $1M in total compensation, including $309K in salary, at Cerevel Therapeutics Holdings in 2021.
Source: SEC filing on April 28, 2022.
Related executives
We found eight more executives who work or worked at Cerevel Therapeutics Holdings.
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
Abraham Ceesay
Cerevel Therapeutics Holdings
President
Kathy Yi
Cerevel Therapeutics Holdings
Chief Financial Officer
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
Scott Akamine
Cerevel Therapeutics Holdings
Chief Legal Officer
Kathleen MA
Cerevel Therapeutics Holdings
Chief Corporate Affairs Officer
Bryan Phillips
Cerevel Therapeutics Holdings
Chief Legal Officer
John Renger
Cerevel Therapeutics Holdings